2013•China Modern MedicineRequires access

Clinical research for large doses of ambroxol in the auxiliary treatment of severe pneumonia in children

Yuanyuan Ma

Open publisher page 0 citations

Abstract

Objective To observe the efficacy and security of large doses of ambroxol in the auxiliary treatment of severe pneumonia in children.Methods Ninety-eight patients with severe pneumonia were randomly divided into treatment group and control group.The two groups were all given conventional treatment.On the basis of conventional treatment,the treatment group was treated by large doses of ambroxol [30 mg/(kg·d)],and the control group was given conventional doses of ambroxol [7.5 mg/(kg·d)].The courses of treatment were 7-10 d.Results The symptom,body advertises alleviated early in treatment control,and the inflammation index sign and cell factor of the treatment group more obviously lower than that of control group.The total effective rate of treatment group and control group were separately 92.00% and 72.92%,that of the treatment was more obviously high than the control group.And the time of antibiotics application in the treatment grou was less than that of control group,the difference was statistically significant(P 0.05).Conclusion The large doses of ambroxol used for treating severe pneumonia in children is favourable and safe.

About this research paper

What this paper is about

Objective To observe the efficacy and security of large doses of ambroxol in the auxiliary treatment of severe pneumonia in children.Methods Ninety-eight patients with severe pneumonia were randomly divided into treatment group and control group.The two groups were all given conventional treatment.On the basis of conventional treatment,the treatment group was treated by large doses of ambroxol [30 mg/(kg·d)],and the control group was given conventional doses of ambroxol [7.5 mg/(kg·d)].The courses of treatment were 7-10 d.Results The symptom,body advertises alleviated early in treatment control,and the inflammation index sign and cell factor of the treatment group more obviously lower than that of control group.The total effective rate of treatment group and control group were separately 92.00% and 72.92%,that of the treatment was more obviously high than the control group.And the time of antibiotics application in the treatment grou was less than that of control group,the difference was statistically significant(P 0.05).Conclusion The large doses of ambroxol used for treating severe pneumonia in children is favourable and safe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy and security of large doses of ambroxol in the auxiliary treatment of severe pneumonia in children.Methods Ninety-eight patients with severe pneumonia were randomly divided into treatment group and control group.The two groups were all given conventional treatment.On the basis of conventional treatment,the treatment group was treated by large doses of ambroxol [30 mg/(kg·d)],and the control group was given conventional doses of ambroxol [7.5 mg/(kg·d)].The courses of treatment were 7-10 d.Results The symptom,body advertises alleviated early in treatment control,and the inflammation index sign and cell factor of the treatment group more obviously lower than that of control group.The total effective rate of treatment group and control group were separately 92.00% and 72.92%,that of the treatment was more obviously high than the control group.And the time of antibiotics application in the treatment grou was less than that of control group,the difference was statistically significant(P 0.05).Conclusion The large doses of ambroxol used for treating severe pneumonia in children is favourable and safe.

Key concepts: Ambroxol, Medicine, Treatment and control groups, Pneumonia, Antibiotics, Conventional treatment, Anesthesia, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical research for large doses of ambroxol in the auxiliary treatment of severe pneumonia in children — Research Paper | ScholarLens